Latest Breaking News On - Published april - Page 1 : vimarsana.com

Tirzepatide Significantly Reduces Weight in Patients with OSA

New analysis from SURMOUNT-1 support the use of GLP-1/GIP agonist tirzepatide to reduce weight in patients with OSA and obesity/overweight.

United statesRon grunsteinCircadian research groupWoolcock instituteEli lilly sponsoredAssociated professional sleep societiesTout tirzepatideWeight lossPublished april

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaFrance generalUnited statesSan antonioSloan simpsonIsabella zinckSatoshi sugimotoParag mahantiNicole zinsli sommMarlena abdinoorJeff legosJonathan grahamMichael meoImke kappesDenisea yardleyEuropean society of medical oncology congress

4 Genius Gems To Boost That Credit Score

Delinquent payments and collections can have a major negative impact on a credit score. Here's how you can avoid that trap.

Christian anniceGems to boost that creditPublished april

Measles Outbreak Control: CDC s Dynamic Modeling and Mass Vaccination Strategies

Measles Outbreak Control: CDC s Dynamic Modeling and Mass Vaccination Strategies
infectioncontroltoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infectioncontroltoday.com Daily Mail and Mail on Sunday newspapers.

United statesPatriciaa stinchfieldNational foundation for infectious diseasesAdobe stockNational foundationInfectious diseasesHow complacency associated with immunizationsPublished februaryTime useDynamic model to measurePublic health interventionsMeasles outbreak sizeMortality weekly reportPublished mayMeasles cases callsPublished april

Kevin Peterson, MD, MPH: Incretin Therapy s Potential

With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.

United statesKevin petersonCampbellp semaglutideAmerican diabetes associationAmerican academy of physician associatesUniversity of minnesotaEditorial advisory boardAmerican academyPhysician associatesPublished decemberPublished mayUse lowers anemia riskPublished marchDisplay reno protective benefitSickle cellPublished april